发明名称 |
composição farmacêutica, e, método de tratamento de uma doença autoimune |
摘要 |
The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject in a dose of the agent from 10 mg to 200 mg. |
申请公布号 |
BRPI0909180(A2) |
申请公布日期 |
2016.08.09 |
申请号 |
BR2009PI09180 |
申请日期 |
2009.03.10 |
申请人 |
BIOTEST AG |
发明人 |
ANDREA WARTENBERG-DEMAND;BENJAMIN DAELKEN;CHRISTOPH BRUECHER;CHRISTOPH UHEREK;DANIELE WOLF;ELMAR KRAUS;FRANK OSTERROTH;JUERGEN LINDNER;MATTHIAS GERMER;SIBYLLE KAISER;SILKE AIGNER |
分类号 |
A61K39/395;A61P37/06;C07K16/28;C07K16/46 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|